About: The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2006 (uk) im Mai 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2006 (ast) scientific article published on 01 May 2006 (en)
publication date	wds:Q83116457-42EEC74C-DF86-4CA5-A171-152A52ED6945
publication date	2006-05-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q83116457-02D9BB8F-01F5-4572-9C9D-62AF57BC30E8 wds:Q83116457-70C3271A-77D6-4EF9-B7C7-3BDB5D94036F wds:Q83116457-828FE85B-14EC-493A-B46A-35659E05EBE3 wds:Q83116457-BDDF2259-B00B-473E-A9BB-F3E9486B0C88
author name string	Haluk Ozen Ferruh Zorlu Rauf Taner Divrik Umit Yildirim
rdfs:label	The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial (en) The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial (nl)
skos:prefLabel	The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial (en) The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial (nl)
name	The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial (en) The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial (nl)
title	wds:Q83116457-A070B6B1-C393-480F-A8A3-DF21682E00A9
title	The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial (en)
page(s)	wds:Q83116457-9B962E1A-CE28-45FE-8E8C-960C5BE39B69
page(s)	1641-1644
instance of	wds:Q83116457-8DD587EB-F254-40F2-8B39-7F7DE562E89C
instance of	scholarly article
PubMed ID	wds:Q83116457-3F7057BF-14CB-4E7F-8720-D8EB9848D548
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16600720
PubMed ID	16600720
published in	wds:Q83116457-75481EEB-AFBF-480A-B9A9-F3DE6ADD5490
published in	Journal of Urology
issue	wds:Q83116457-571D9685-3BD2-454F-8986-CDB6F41DAA74
volume	wds:Q83116457-2515A9C4-1937-430D-99C5-6B6FDEEDE97B
issue	5
volume	175
DOI	wds:Q83116457-1AD0B725-F835-44DC-A906-73AD5F389F92
DOI	http://dx.doi.org/10.1016/S0022-5347(05)01002-5
DOI	10.1016/S0022-5347(05)01002-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q83116457
is cites work of	Bladder cancer: narrowing the gap between evidence and practice Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences? Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors--results of a prospective, randomized comparison to the standard approach Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder Best practice in the treatment of nonmuscle invasive bladder cancer Bladder cancer [EAU guidelines on non-muscle-carcinoma of the bladder] Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries Urothelial carcinoma of the bladder: definition, treatment and future efforts Contemporary management of low-risk bladder cancer Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy Bladder cancer. GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer Guideline of guidelines: non-muscle-invasive bladder cancer A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer Bladder cancer: new TUR techniques The role of single instillation chemotherapy in patients who receive subsequent bacillus Calmette-Guérin: A retrospective single centre study, and systematic review of the literature Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE) Second transurethral resection in T1G3 bladder tumors - Selectively avoidable? The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer Utility of restage transurethral resection of bladder tumor Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December Results of second transurethral resection for high-grade T1 bladder cancer Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion? The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease CUA guidelines on the management of non-muscle invasive bladder cancer T1 bladder cancer: current considerations for diagnosis and management The optimal management of T1 high-grade bladder cancer. The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy Three-gene signature predicts disease progression of non-muscle invasive bladder cancer. Advances in risk stratification of bladder cancer to guide personalized medicine. Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality [Non-muscle-invasive bladder cancer: Information transfer from the clinic to the doctor's office : Results of a questionnaire study and presentation of a software solution]. Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what Bladder cancer in 2016: News in diagnosis, treatment, and risk group assessment Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size Non-muscle invasive bladder cancer: Are epicrises the 'Bermuda Triangle' of information transfer? Bladder cancer: Restaging TUR reduces recurrence and progression risk Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder 2017. Long-term Bladder and Upper Urinary Tract Follow-up Recurrence and Progression Rates of G1-2 Non-muscle-invasive Urothelial Carcinoma of the Bladder Improving urologic cancer care Is there a role for second transurethral resection in pTa high-grade urothelial bladder cancer? Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database. Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta Can a second resection be avoided after initial thulium laser endoscopic en bloc resection for non-muscle invasive bladder cancer? A retrospective single-center study of 251 patients Clinical utility of fluorescence in situ hybridization for prediction of residual tumor after transurethral resection of bladder urothelial carcinoma Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guérin immunotherapy? Editorial comment Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic review Saudi Oncology Society clinical management guidelines for urinary bladder cancer. An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer Is 'second-look' (re-staging) transurethral resection of bladder tumours a new standard of care? [Therapeutic effect of mitomycin C in the immediate postoperative period in patients with intermediate-risk non-muscle-invasive bladder tumors] [Oncological diseases and postoperative alterations of the bladder and urinary tract] Is Repeat Transurethral Resection Always Needed in High-Grade T1 Bladder Cancer?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software